Browse By Last Name
Search




   
John D. Amorosi
Partner
Mr. Amorosi is a member of Davis Polk’s Corporate Department, concentrating in mergers and acquisitions. He has regularly acted for both strategic clients such as CVS, E*TRADE, Masco, CNOOC and Morgan Stanley, and private equity clients such as MSCP, Crestview, Metalmark, Corsair and Perry Capital.

Mr. Amorosi has extensive experience in the full range of M&A transactions. He has been involved in numerous contested and uncontested public company transactions. He has also advised clients on various private M&A transactions and auctions, and has represented a range of clients in relation to various joint ventures and special situations. He also has been involved in many transactions involving international acquirors and targets with particular focus on M&A transactions in Brazil and Asia.
Contact
Bar Admissions
  • State of New York
Education
  • B.A., Georgetown University, 1991
    • cum laude
  • J.D., Georgetown University Law Center, 1995
    • magna cum laude
    • Order of the Coif

Work Highlights
Public Company M&A
  • CVS on its $26 billion combination with Caremark Rx, its $9.6 billion consortium purchase of Albertson’s and its $2.9 billion purchase of Longs Drug Stores
  • ARM Holdings in its $1 billion acquisition of Artisan Components
  • Morgan Stanley on its acquisition of Saxon Capital for $800 million
Contested Transactions
  • CVS in successfully (a) fending off a hostile competing offer and proxy solicitation by Express Scripts in order to complete its $26 billion deal with Caremark Rx and (b) overcoming a hostile competing offer by Walgreens and the objections of Pershing Square in order to consummate its $2.9 billion acquisition of Longs Drug Stores 
  • CNOOC in connection with its attempted acquisition of Unocal for $18.5 billion
  • RJR Nabisco on its various proxy contests with Bennett LeBow and Carl Icahn
Private Strategic M&A/Auctions
  • Morgan Stanley on the sale of its aircraft leasing business to Terra Firma for $2.5 billion and its retail asset management business to Invesco for $1.5 billion 
  • RJR Nabisco on the sale of its international tobacco business to Japan Tobacco for $7.8 billion
Joint Ventures/Restructurings/Unconventional M&A Transactions
  • Federal Reserve Bank of New York and the U.S. Treasury in connection with multiple transactions involving AIG, including the $25 billion debt-for-equity exchanges involving AIG’s Asian insurance subsidiaries, AIA and ALICO
  • Morgan Stanley on the formation of its investment banking joint venture in Japan with Mitsubishi UFJ Financial Group 
  • RJR Nabisco in connection with its reorganization, which included the spin-off of its U.S. tobacco business, the sale of its international tobacco business and various debt tenders
  • E*TRADE on its sale of a portfolio of asset-backed securities to Citadel and in connection with an investment by Citadel in E*TRADE for $2.55 billion
Cross-border Transactions/Brazil and Asia
  • MMX Mineraçao on its breakup into three different companies and the subsequent sale of one of them to Anglo American for $5.6 billion
  • Cosan on the formation of a $12 billion sugar, ethanol and downstream fuel joint venture with Royal Dutch Shell
  • Qualicorp Particpaçoes S.A. on its sale to Carlyle 
  • ARM Holdings in its $1 billion acquisition of Artisan Components
  • CNOOC in connection with its attempted acquisition of Unocal for $18.5 billion
Of Note
  • The New York Times listed Mr. Amorosi, along with several other Davis Polk partners, as one of the leading dealmakers on Wall Street under 40 years of age (“Facebook of Wall Street’s Future,” NYT, Oct. 3, 2007).

  • He is listed as one of the leading M&A lawyers in Chambers Global, one of the leading private equity lawyers in Legalease’s The Legal 500 United States and as one of the leading Latin American M&A lawyers in both Chambers and Latin Lawyer.

  • He has also spoken as a panelist on a number of occasions at the Harvard Asia Business Conference regarding cross-border M&A transactions in Asia and chaired the M&A panels at various PLI private equity symposiums.
Professional History
  • Partner, 2003-present
  • Associate, 1995-2003
  • Menlo Park office, 2004
  • London office, 1999-2001